Financial Security Advisor’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
2,616
+8
+0.3% +$2.97K 0.16% 64
2026
Q1
$763K Buy
2,608
+425
+19% +$140K 0.14% 67
2025
Q4
$765K Sell
2,183
-87
-4% -$29.4K 0.15% 62
2025
Q3
$734K Buy
2,270
+44
+2% +$13.7K 0.16% 62
2025
Q2
$866K Buy
2,226
+4
+0.2% +$1.61K 0.2% 51
2025
Q1
$966K Sell
2,222
-106
-5% -$42.6K 0.25% 44
2024
Q4
$859K Buy
2,328
+4
+0.2% +$1.67K 0.22% 49
2024
Q3
$1.21M Buy
2,324
+2
+0.1% +$1.07K 0.3% 39
2024
Q2
$1.26M Buy
2,322
+3
+0.1% +$1.59K 0.42% 35
2024
Q1
$1.2M Buy
2,319
+3
+0.1% +$1.49K 0.42% 33
2023
Q4
$1.09M Sell
2,316
-41
-2% -$19K 0.43% 35
2023
Q3
$1.03M Buy
+2,357
New +$1.07M 0.47% 29

Other funds holding ELV

Financial Security Advisor's ELV Position: Q2 2026 in Review

Financial Security Advisor increased its Elevance Health (ELV) stake by 0.31% in Q2 2026, buying an estimated $2.97K and bringing the position to 2,616 shares worth $1.01M. The position accounts for 0.16% of the portfolio, ranked #64.

Financial Security Advisor first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.26M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Financial Security Advisor held 2,616 shares of Elevance Health worth $1.01M as of Q2 2026.
  • Financial Security Advisor bought 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
  • Elevance Health made up 0.16% of Financial Security Advisor's portfolio in Q2 2026, its #64 holding.
  • Financial Security Advisor first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • Financial Security Advisor's Elevance Health position peaked at $1.26M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.